Watch an expert discussion on the latest treatments for chronic lymphocytic leukaemia (CLL), with a panel of global experts and an interactive session.

Paula Cramer (Germany), Robin Foà (Italy), Steve Coutre (USA), Constantine Tam (Australia) review the data presented during the XVI International Workshop on Chronic Lymphocytic Leukaemia (iwCLL) with a particular focus on the B-cell receptor and the novel agents that target the BCR-signalling pathways.

After viewing this broadcast, you should be able to discuss the role of agents that target the B-cell receptor signalling pathways in the management of patients with CLL.

This programme has been supported by an unrestricted educational grant from Janssen Pharmaceutica (A Johnson & Johnson Company).